Literature DB >> 20309698

[The G-DRG System 2009--relevant changes for rheumatology].

W Fiori1, A Liedtke-Dyong, H-J Lakomek, K Buscham, H Lehmann, W Liman, A-K Fuchs, F Bessler, N Roeder.   

Abstract

The following article presents the major general and specific changes in the G-DRG system, in the classification systems for diagnoses and procedures as well as for the billing process for 2010. Since the G-DRG system is primarily a tool for the redistribution of resources, every hospital needs to analyze the economic effects of the changes by applying the G-DRG transition-grouper to its own cases. Depending on their clinical focus, rheumatological departments may experience positive or negative consequences from the adjustments. In addition, relevant current case law is considered.

Mesh:

Year:  2010        PMID: 20309698     DOI: 10.1007/s00393-010-0606-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  4 in total

Review 1.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

2.  [G-DRG system 2009: relevant changes for rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

3.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

4.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955

  4 in total
  4 in total

1.  [Hospital financing in 2015. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

2.  [Hospital financing in 2013: relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

3.  [Hospital financing in 2014. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 4.  [Hospital financing in 2016. Relevant changes for rheumatology].

Authors:  W Fiori; H Bunzemeier; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.